{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06163326",
            "orgStudyIdInfo": {
                "id": "B7981041"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505804-42-00",
                    "type": "REGISTRY",
                    "domain": "CTIS (EU)"
                }
            ],
            "organization": {
                "fullName": "Pfizer",
                "class": "INDUSTRY"
            },
            "briefTitle": "A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo",
            "officialTitle": "A PHASE 3 RANDOMIZED WITHDRAWAL AND DOSE-UP TITRATION, MULTICENTER EXTENSION STUDY INVESTIGATING THE SAFETY, EFFICACY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO",
            "acronym": "Tranquillo LTE",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-week-study-to-learn-about-the-safety-and-effects-of-ritlecitinib-in-participants-with-nonsegmental-vitiligo"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-01-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-30",
            "studyFirstSubmitQcDate": "2023-11-30",
            "studyFirstPostDateStruct": {
                "date": "2023-12-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Pfizer",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV).\n\nRitlecitinib is studied in patients with non-segmental vitiligo. Vitiligo is a chronic acquired depigmentation disorder characterized by well-defined pale white patches of skin.\n\nNon-segmental vitiligo is an autoimmune disorder and is the focus of this study. The study will show:\n\n* if the repigmentation (the recovery of pigmentation) achieved in study B7981040 (also called the \"parent study\") will stay the same or will further increase if you keep receiving the same study medicine (ritlecitinib 50 milligrams or placebo)\n* Or if more repigmentation can be achieved if you start receiving ritlecitinib 100 milligrams in this study\n* Or how long the repigmentation achieved during the parent study lasts if you start receiving placebo in this study.\n\nThis study is seeking for participants who:\n\n* have non-segmental vitiligo (either active or stable) and\n* received ritlecitinib or placebo for 52 weeks in the parent study. A placebo looks exactly like the study capsule but does not contain any medicine in it.\n\nAll participants in this study will receive the study medicine or placebo. The study medicine (ritlecitinib 50 milligrams or 100 milligrams) or placebo are capsules that are taken by mouth at home every day. At week 4 (or if it cannot be done then, at week 8) study visit, you must take the medication at the study site, and not at home.\n\nParticipants may receive the study medicine or placebo for up to 52 weeks.\n\nThe study will look at the experiences of people receiving the study medicine. This will help see if ritlecitinib is better for treating vitiligo.\n\nParticipants will be involved in this study for a maximum of 60 weeks. During this time, they will have 9 study visits during the study.\n\nRitlecitinib 50 mg is an approved drug for the treatment of severe Alopecia Areata (a disease with similar abnormal changes in the body functions like vitiligo) in the US, EU and Japan. China, Great Britain and other market applications are pending."
        },
        "conditionsModule": {
            "conditions": [
                "Vitiligo"
            ],
            "keywords": [
                "Stable vitiligo",
                "Active vitiligo",
                "Adults",
                "Adolescents"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who previously received 1 ritlecitinib 50 mg capsule QD orally from BL to Week 52 in Study B7981040.\n\nRitlecitinib 50 mg or Ritlecitinib 100 mg or Placebo will be assigned.",
                    "interventionNames": [
                        "Drug: Ritlecitinib",
                        "Drug: Ritlecitinib 100 mg",
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Arm 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who previously received 1 placebo 50 mg capsule QD orally from BL to Week 52 in Study B7981040 Ritlecitinib 50 mg or Ritlecitinib 100 mg or Placebo will be assigned",
                    "interventionNames": [
                        "Drug: Ritlecitinib",
                        "Drug: Ritlecitinib 100 mg",
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Ritlecitinib",
                    "description": "Ritlecitinib 50 mg capsule once daily",
                    "armGroupLabels": [
                        "Arm 1",
                        "Arm 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ritlecitinib 100 mg",
                    "description": "Ritlecitinib 100 mg capsule once daily",
                    "armGroupLabels": [
                        "Arm 1",
                        "Arm 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Matching capsule once daily",
                    "armGroupLabels": [
                        "Arm 1",
                        "Arm 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), and adverse events (AEs) leading to discontinuation",
                    "description": "To evaluate the long-term safety and tolerability of ritlecitinib in adult and adolescent participants with non-segmental vitiligo",
                    "timeFrame": "Screening up to at least 30 days after last dose of study drug (week 52 or Early Termination)"
                },
                {
                    "measure": "Incidence of clinically significant laboratory abnormalities",
                    "description": "To evaluate the long-term safety and tolerability of ritlecitinib in adult and adolescent participants with non-segmental vitiligo",
                    "timeFrame": "Screening up to at least 30 days after last dose of study drug (week 52 or Early Termination)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Response based on T-VASI75 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 75% improvement in T-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on F-VASI75 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 75% improvement in F-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on T-VASI50 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 50% improvement in T-VASI from Baseline",
                    "timeFrame": "Baseline to Week 52"
                },
                {
                    "measure": "Response based on F-VASI50 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 50% improvement in F-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on T-VASI90 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 90% improvement in T-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on F-VASI90 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 90% improvement in F-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on T-VASI100 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 100% improvement in T-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Response based on F-VASI100 at weeks 4, 8, 12, 24, 36 and 52",
                    "description": "Proportion of participants achieving at least a 100% improvement in F-VASI from Baseline",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Patient Global Impression of Severity-Face (PGIS-F) at weeks 24, 36, and 52",
                    "description": "To assess the effect of ritlecitinib compared to placebo on the PGIC-F at weeks 24, 36, and 52",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Patient Global Impression of Severity-Overall Vitiligo (PGIS-V) at weeks 24, 36, and 52",
                    "description": "To assess the effect of ritlecitinib compared to placebo on the PGIC-V at Week 24, 36, and 52",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Patient Global Impression of Change-Face (PGIC-F) at week 24, 36, and 52",
                    "description": "To assess the effect of ritlecitinib compared to placebo on the PGIC-F at Week 24, 36, and 52",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Patient Global Impression of Change- Overall vitiligo (PGIC-V) at weeks 24, 36, and 52",
                    "description": "To assess the effect of ritlecitinib compared to placebo on the PGIC-V at weeks 24, 36, and 52",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Proportion of participants achieving disease stabilization",
                    "description": "The difference in the proportion of participants with stable disease at all scheduled timepoints",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Percentage change from baseline (%CFB) in F-VASI at weeks 4, 8, 12, 24, 36, and 52",
                    "description": "To compare the efficacy of ritlecitinib 100mg QD, 50mg QD, and placebo",
                    "timeFrame": "Baseline to week 52"
                },
                {
                    "measure": "Percentage change from baseline (%CFB) in T-VASI at weeks 4, 8, 12, 24, 36, and 52",
                    "description": "To compare the efficacy of ritlecitinib 100mg QD, 50mg QD, and placebo",
                    "timeFrame": "Baseline to week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants \u226518 years of age at Screening in Study B7981040. Adolescents (12 to \\<18 years of age at Screening in the parent study) are also eligible for this study if approved by the local IRB/EC and regulatory health authority.\n* Participants who met the eligibility criteria and completed 52 weeks of study intervention for stable or active nonsegmental vitiligo in Study B7981040\n* The BL visit/first dose in Study B7981041 must be within 30 days after the week 52 visit in Study B7981040\n\nExclusion Criteria:\n\n* Participant met the parent study (Study 7981040) discontinuation criteria or discontinued the parent study for any safety-related event\n* Any active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "role": "CONTACT",
                    "phone": "1-800-718-1021",
                    "email": "ClinicalTrials.gov_Inquiries@pfizer.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "affiliation": "Pfizer",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "California Dermatology & Clinical Research Institute",
                    "status": "RECRUITING",
                    "city": "Encinitas",
                    "state": "California",
                    "zip": "92024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.03699,
                        "lon": -117.29198
                    }
                },
                {
                    "facility": "Marvel Clinical Research",
                    "status": "RECRUITING",
                    "city": "Huntington Beach",
                    "state": "California",
                    "zip": "92647",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.6603,
                        "lon": -117.99923
                    }
                },
                {
                    "facility": "Wallace Medical Group, Inc",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90056",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Encore Medical Research of Boynton Beach",
                    "status": "RECRUITING",
                    "city": "Boynton Beach",
                    "state": "Florida",
                    "zip": "33436",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.52535,
                        "lon": -80.06643
                    }
                },
                {
                    "facility": "Skin Care Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Hollywood",
                    "state": "Florida",
                    "zip": "33021",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.0112,
                        "lon": -80.14949
                    }
                },
                {
                    "facility": "ForCare Clinical Research",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33613",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Dawes Fretzin Clinical Research Group, LLC",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46250",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "DelRicht Research",
                    "status": "RECRUITING",
                    "city": "Baton Rouge",
                    "state": "Louisiana",
                    "zip": "70809",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.45075,
                        "lon": -91.15455
                    }
                },
                {
                    "facility": "Visage Dermatology and Aesthetic Center",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Largo",
                    "state": "Maryland",
                    "zip": "20774",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.89761,
                        "lon": -76.83025
                    }
                },
                {
                    "facility": "Accellacare - Wilmington",
                    "status": "RECRUITING",
                    "city": "Wilmington",
                    "state": "North Carolina",
                    "zip": "28411",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22573,
                        "lon": -77.94471
                    }
                },
                {
                    "facility": "Wilmington Health, PLLC",
                    "status": "RECRUITING",
                    "city": "Wilmington",
                    "state": "North Carolina",
                    "zip": "28411",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22573,
                        "lon": -77.94471
                    }
                },
                {
                    "facility": "Remington Davis Clinical Research",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Remington-Davis, Inc",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Austin Institute for Clinical Research",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77056",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "CARe Clinic",
                    "status": "RECRUITING",
                    "city": "Red Deer",
                    "state": "Alberta",
                    "zip": "T4P 1K4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 52.26682,
                        "lon": -113.802
                    }
                },
                {
                    "facility": "Lynderm Research Inc.",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Markham",
                    "state": "Ontario",
                    "zip": "L3P 1X3",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.86682,
                        "lon": -79.2663
                    }
                },
                {
                    "facility": "DermEdge Research",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Mississauga",
                    "state": "Ontario",
                    "zip": "L4Y 4C5",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.5789,
                        "lon": -79.6583
                    }
                },
                {
                    "facility": "North York Research Inc",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M2N3A6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Centre de Recherche Dermatologique du Quebec metropolitain",
                    "status": "RECRUITING",
                    "city": "Quebec",
                    "zip": "G1V 4X7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "Centre de Recherche Saint-Louis",
                    "status": "RECRUITING",
                    "city": "Quebec",
                    "zip": "G1W 4R4",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                },
                {
                    "facility": "Huashan Hospital Fudan University",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "200040",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "First Affiliated Hospital of Kunming Medical University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Kunming",
                    "state": "Yunnan",
                    "zip": "650032",
                    "country": "China",
                    "geoPoint": {
                        "lat": 25.03889,
                        "lon": 102.71833
                    }
                },
                {
                    "facility": "Praxis Leitz und Kollegen",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Stuttgart",
                    "state": "Baden-w\u00fcrttemberg",
                    "zip": "70178",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 48.78232,
                        "lon": 9.17702
                    }
                },
                {
                    "facility": "Fachklinik Bad Bentheim",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bad Bentheim",
                    "state": "Niedersachsen",
                    "zip": "48455",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 52.30077,
                        "lon": 7.15767
                    }
                },
                {
                    "facility": "Tohoku University Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sendai-shi",
                    "state": "Miyagi",
                    "zip": "980-8574",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Tohoku University Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sendai",
                    "state": "Miyagi",
                    "zip": "980-8574",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 38.26667,
                        "lon": 140.86667
                    }
                },
                {
                    "facility": "Dermatology and Ophthalmology Kume Clinic",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sakai City",
                    "state": "Osaka",
                    "zip": "593-8324",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.58333,
                        "lon": 135.46667
                    }
                },
                {
                    "facility": "Dermatology and Ophthalmology Kume Clinic",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Sakai-City",
                    "state": "Osaka",
                    "zip": "593-8324",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.58333,
                        "lon": 135.46667
                    }
                },
                {
                    "facility": "Nippon Medical School Hospital",
                    "status": "RECRUITING",
                    "city": "Bunkyo-ku",
                    "state": "Tokyo",
                    "zip": "113-8603",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.37517,
                        "lon": 139.92991
                    }
                },
                {
                    "facility": "Tokyo Medical University Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Shinjuku-ku",
                    "state": "Tokyo",
                    "zip": "160-0023",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.2946,
                        "lon": 139.57059
                    }
                },
                {
                    "facility": "Yamanashi Prefectural Central Hospital",
                    "status": "RECRUITING",
                    "city": "Kofu",
                    "state": "Yamanashi",
                    "zip": "400-8506",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.66669,
                        "lon": 138.56668
                    }
                },
                {
                    "facility": "Nippon Medical School Hospital",
                    "status": "RECRUITING",
                    "city": "Tokyo",
                    "zip": "113-8603",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.6895,
                        "lon": 139.69171
                    }
                },
                {
                    "facility": "Ajou University Hospital",
                    "status": "RECRUITING",
                    "city": "Suwon",
                    "state": "Ky\u01d2nggi-do",
                    "zip": "16499",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.29111,
                        "lon": 127.00889
                    }
                },
                {
                    "facility": "Severance Hospital, Yonsei University Health System",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul-teukbyeolsi [seoul]",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "DermoDent Centrum Medyczne Aldona Czajkowska Rafa\u0142 Czajkowski s.c.",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Osielsko",
                    "state": "Kujawsko-pomorskie",
                    "zip": "86-031",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.18505,
                        "lon": 18.08418
                    }
                },
                {
                    "facility": "Royalderm Agnieszka Nawrocka",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Warszawa",
                    "state": "Mazowieckie",
                    "zip": "02-962",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Twoja Przychodnia SCM",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Szczecin",
                    "state": "Zachodniopomorskie",
                    "zip": "71-500",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.42894,
                        "lon": 14.55302
                    }
                },
                {
                    "facility": "Dermedic Jacek Zdybski",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ostrowiec Swietokrzyski",
                    "state": "\u015awi\u0119tokrzyskie",
                    "zip": "27-400",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.92936,
                        "lon": 21.38525
                    }
                },
                {
                    "facility": "Hospital Universitario Reina Sofia",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Cordoba",
                    "state": "Andaluc\u00eda",
                    "zip": "14004",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.89155,
                        "lon": -4.77275
                    }
                },
                {
                    "facility": "AUDIKA",
                    "status": "NOT_YET_RECRUITING",
                    "city": "C\u00f3rdoba",
                    "zip": "14001",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.89155,
                        "lon": -4.77275
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "To obtain contact information for a study center near you, click here.",
                    "url": "https://pmiform.com/clinical-trial-info-request?StudyID=B7981041"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.",
            "url": "https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014820",
                    "term": "Vitiligo"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017496",
                    "term": "Hypopigmentation"
                },
                {
                    "id": "D000010859",
                    "term": "Pigmentation Disorders"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17563",
                    "name": "Vitiligo",
                    "asFound": "Vitiligo",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19761",
                    "name": "Hypopigmentation",
                    "relevance": "LOW"
                },
                {
                    "id": "M13754",
                    "name": "Pigmentation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2945",
                    "name": "Hypomelanotic Disorder",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}